{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:06:29Z","timestamp":1720609589914},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1157\/13091219","type":"journal-article","created":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T08:58:48Z","timestamp":1153385928000},"page":"37-45","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S3","title":["Neumon\u00eda nosocomial causada por Staphylococcus aureus resistente a meticilina"],"prefix":"10.1016","volume":"23","author":[{"given":"Despoina","family":"Koulenti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavlos","family":"Myrianthefs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Baltopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13091219_bib1","unstructured":"Staphylococcus. En: Todar's on-line Textbook of Bacteriology. Todar University of Wisconsin-Madison, Department of Bacteriology. 2005."},{"key":"10.1157\/13091219_bib2","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/313461","article-title":"Involvement of Panton-Valentine leukocidin producing Staphylococcus aureus in primary skin infection and pneumonia","volume":"29","author":"Lina","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091219_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/bmj.1.5219.124-a","article-title":"\u201cCelbenin\u201d-resistant Staphylococci","volume":"1","author":"Jevons","year":"1961","journal-title":"Br Med J"},{"key":"10.1157\/13091219_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0213-005X(02)72853-X","article-title":"Surveillance for antimicrobial resistance: VIRA Study","volume":"20","author":"Picazo","year":"2002","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13091219_bib5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1086\/313440","article-title":"Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-sensitive organisms","volume":"29","author":"Gonz\u00e1lez","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091219_bib6","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3201\/eid0702.010204","article-title":"The changing epidemiology of Staphylococcus aureus?","volume":"7","author":"Chambers","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1157\/13091219_bib7","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1097\/01.CCM.0000059437.01924.97","article-title":"Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant gram-negative bacilli and vancomycin-resistant enterococci before and after intensive care unit admission","volume":"31","author":"Ho","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1157\/13091219_bib8","first-page":"367","article-title":"Nasal carriers of methicillin-resistant Staphylococcus aureus among Cuban children attending day-care centers","volume":"19","author":"Torano","year":"2001","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13091219_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00001432-200306000-00001","article-title":"Community-acquired Staphylococcus aureus infections. Increasing virulence and emerging methicillin resistance in the new millennium","volume":"16","author":"Stevens","year":"2003","journal-title":"Curr Opin Infect Dis"},{"key":"10.1157\/13091219_bib10","first-page":"405","article-title":"Methicillin-resistant Staphylococcus aureus infections in ICU patients Anesthesiology","volume":"3","author":"Sista","year":"2004","journal-title":"Clin N Am"},{"key":"10.1157\/13091219_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/pmj.78.921.385","article-title":"Methicillin resistant Staphylococcus aureus (SARM) in the intensive care unit","volume":"78","author":"Haddaddin","year":"2002","journal-title":"Postgrad Med J"},{"key":"10.1157\/13091219_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9343(93)90063-U","article-title":"Methicillin-Resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management","volume":"94","author":"Mulligan","year":"1993","journal-title":"Am J Med"},{"key":"10.1157\/13091219_bib13","first-page":"37","article-title":"SARM their treatment in the ICU","volume":"24","author":"Fguia","year":"2003","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1157\/13091219_bib14","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1164\/ajrccm.150.6.7952612","article-title":"Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin sensitive episodes","volume":"150","author":"Rello","year":"1994","journal-title":"Am J Crit Care Med"},{"key":"10.1157\/13091219_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.274.8.639","article-title":"The prevalence of nosocomial infection in intensive care units in Europe","volume":"274","author":"Vincent","year":"1995","journal-title":"JAMA"},{"key":"10.1157\/13091219_bib16","first-page":"622","article-title":"Clinical and epidemiological findings in mechanically-ventilated patients with methicillin-resistant Staphylococcus aureus pneumonia","volume":"17","author":"Pujol","year":"1998","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13091219_bib17","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1378\/chest.117.5.1434","article-title":"A comparative analysis of patients with early-onset vs. late-onset nosocomial pneumonia in the ICU setting","volume":"117","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1157\/13091219_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0272-5231(21)00981-3","article-title":"Pneumonia due to Staphylococcus aureus infection","volume":"16","author":"Al-Ujayli","year":"1995","journal-title":"Clin Chest Med"},{"key":"10.1157\/13091219_bib19","first-page":"725","article-title":"The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention","volume":"50","author":"Safdar","year":"2005","journal-title":"Res Care"},{"key":"10.1157\/13091219_bib20","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.200403-346OC","article-title":"Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia","volume":"170","author":"Combes","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13091219_bib21","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1378\/chest.97.4.788","article-title":"The clinical spectrum of Staphylococcus aureus pulmonary infection","volume":"97","author":"Kaye","year":"1990","journal-title":"Chest"},{"key":"10.1157\/13091219_bib22","doi-asserted-by":"crossref","unstructured":"Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.","DOI":"10.1164\/rccm.200405-644ST"},{"key":"10.1157\/13091219_bib23","first-page":"965","article-title":"Clinical approach to the patient with suspected ventilator-associated pneumonia","volume":"50","author":"Vidaur","year":"2005","journal-title":"Respir Care"},{"key":"10.1157\/13091219_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.7326\/0003-4819-77-5-701","article-title":"Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract","volume":"77","author":"Johanson","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1157\/13091219_bib25","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1183\/09031936.02.00012902","article-title":"Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome","volume":"20","author":"Nseir","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1157\/13091219_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1164\/ajrccm\/147.1.211","article-title":"Diagnosis of pneumonia in mechanically ventilated patients: repeatability of the protected specimen brush","volume":"147","author":"Marquette","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1157\/13091219_bib27","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1164\/rccm.200202-130CP","article-title":"Effect of design-related bias in studies of diagnostic tests for ventilator-associated pneumonia","volume":"166","author":"Michaud","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13091219_bib28","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1164\/ajrccm.150.2.8049850","article-title":"Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia","volume":"150","author":"Chastre","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13091219_bib29","doi-asserted-by":"crossref","first-page":"198S","DOI":"10.1378\/chest.117.4_suppl_2.198S","article-title":"Bronchoscopic BAL in the diagnosis of ventilator- associated pneumonia","volume":"117","author":"Torres","year":"2000","journal-title":"Chest"},{"issue":"Suppl","key":"10.1157\/13091219_bib30","doi-asserted-by":"crossref","first-page":"N82","DOI":"10.1097\/00003246-200104001-00005","article-title":"Impact of gram-positive resistance on outcome of nosocomial pneumonia","volume":"29","author":"Bodi","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1157\/13091219_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1378\/chest.112.2.445","article-title":"The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria","volume":"112","author":"Kirtland","year":"1997","journal-title":"Chest"},{"key":"10.1157\/13091219_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00003246-199802000-00017","article-title":"Diagnostic accuracy of protected specimen brush and bronchoalveolar lavage in nosocomial pneumonia: impact of previous antimicrobial treatments","volume":"26","author":"Souweine","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1157\/13091219_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccm.2004.10.017","article-title":"Etiology of Ventilator-Associated Pneumonia","volume":"26","author":"Rello","year":"2005","journal-title":"Clin Chest Med"},{"key":"10.1157\/13091219_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/jhin.2001.0960","article-title":"SARM in the critically ill","volume":"48","author":"Theaker","year":"2001","journal-title":"J Hosp Infect"},{"key":"10.1157\/13091219_bib35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1345\/aph.1E028","article-title":"Clinical and economic analysis of methicillin-susceptible and resistant Staphylococcus aureus infections","volume":"38","author":"Kopp","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1157\/13091219_bib36","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/jama.282.18.1745","article-title":"Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit","volume":"282","author":"Chaix","year":"1999","journal-title":"JAMA"},{"key":"10.1157\/13091219_bib37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1086\/502357","article-title":"Occurrence of co-colonization or co-infection with VRE and SARM in a medical intensive care unit","volume":"25","author":"Warren","year":"2004","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1157\/13091219_bib38","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1128\/JCM.41.2.586-591.2003","article-title":"Clonal diversity among streprogramin A-resistant Staphylococcus aureus isolates collected in French hospitals","volume":"41","author":"Haroche","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1157\/13091219_bib39","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00134-005-2679-0","article-title":"Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units","volume":"31","author":"Lucet","year":"2005","journal-title":"Intens Care Med"},{"key":"10.1157\/13091219_bib40","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0733-8651(03)00030-4","article-title":"Staphylococcus aureus bacteremia and endocarditis","volume":"21","author":"Petti","year":"2003","journal-title":"Cardiol Clin"},{"key":"10.1157\/13091219_bib41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/377735","article-title":"Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review","volume":"37","author":"Laupland","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13091219_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF01695658","article-title":"Predominant pathogens found in the European Prevalence of infection in Intensive Care Unit","volume":"15","author":"Spencer","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1157\/13091219_bib43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00134-003-1715-1","article-title":"Therapy of ventilator-associated pneumonia. A patient-based strategy based on the ten rules of the \u2018Tarragona Strategy\u2019","volume":"29","author":"Sandiumenge","year":"2003","journal-title":"Intens Care Med"},{"issue":"Supl. 3","key":"10.1157\/13091219_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1157\/13091216","article-title":"Enfoque cl\u00ednico del paciente con neumon\u00eda asociada a ventilaci\u00f3n mec\u00e1nica","volume":"23","author":"Vidaur","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"suppl. 4","key":"10.1157\/13091219_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1469-0691.2005.01162.x","article-title":"Methicillin-resistant Staphylococcus aureus: clinical manifestations and antimicrobial therapy","volume":"11","author":"Cunha","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13091219_bib46","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5520(05)70258-0","article-title":"Antibiotics for Gram positive bacterial infections: vancomycin, teicoplanin, quiniupristin\/dalfopristin and linezolid","volume":"14","author":"Lundestrom","year":"2000","journal-title":"Infect Dis Clin North Am"},{"key":"10.1157\/13091219_bib47","doi-asserted-by":"crossref","unstructured":"Rello J, Sol\u00e9-Viol\u00e1n J, Sa-Borges M, Garnacho-Montero J, Mu\u00f1oz E, Sirgo G, et al. Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides [En prensa]. Crit Care Med. 2005.","DOI":"10.1097\/01.CCM.0000178180.61305.1D"},{"key":"10.1157\/13091219_bib48","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1378\/chest.124.5.1789","article-title":"Linezolid versus vancomycine:analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"Wunderink","year":"2003","journal-title":"Chest"},{"key":"10.1157\/13091219_bib49","first-page":"59","article-title":"Administraci\u00f3n de antibi\u00f3ticos en las neumon\u00edas: visi\u00f3n desde el Mediterr\u00e1neo","volume":"18","author":"Rello","year":"2000","journal-title":"Enferm Infecc Microbiol"},{"key":"10.1157\/13091219_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.37.2.281","article-title":"Analysis of vancomycin entry into the pulmonary epithelial lining fluid by bronchoalveolar lavage in critically ill patients","volume":"37","author":"Lamer","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13091219_bib51","first-page":"138S","article-title":"Outcome of ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus","author":"Leeper","year":"2000","journal-title":"Chest"},{"key":"10.1157\/13091219_bib52","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/57.suppl_2.S4","article-title":"Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus","volume":"57","author":"Moise","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"10.1157\/13091219_bib53","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0924-8579(03)00046-3","article-title":"Vancomycin for Staphylococcus aureus therapy of respiratory tract infections: the end of an era?","volume":"21","author":"Nathwani","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1157\/13091219_bib54","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AAC.46.5.1475-1480.2002","article-title":"Intrapulmonary pharmacokinetics of linezolid","volume":"46","author":"Conte","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13091219_bib55","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1157\/13091219_bib56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00134-003-2135-y","article-title":"Linezolid in VAP by SARM : a better choice?","volume":"30","author":"Ioanas","year":"2004","journal-title":"Intens Care Med"},{"key":"10.1157\/13091219_bib57","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00134-003-2088-1","article-title":"Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin","volume":"30","author":"Kollef","year":"2004","journal-title":"Intens Care Med"},{"key":"10.1157\/13091219_bib58","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1164\/ajrccm.161.3.9904115","article-title":"Treatment of Gram-positive nosocomial pneumonia: a prospective randomized comparison of quinapristin\/dalfopristin versus vancomycine; Nosocomial Pneumonia Group","volume":"161","author":"Fagon","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1157\/13091219_bib59","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1592\/phco.24.1.41.34802","article-title":"Daptomycin","volume":"24","author":"Tedesco","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1157\/13091219_bib60","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/427701","article-title":"Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic and therapeutic odyssey","volume":"40","author":"Deresinski","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"Suppl 3","key":"10.1157\/13091219_bib61","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1469-0691.2005.01141.x","article-title":"The need for new therapeutic agents: what is the pipeline?","volume":"11","author":"Shah","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13091219_bib62","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.mib.2005.07.001","article-title":"Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria","volume":"8","author":"Appelbaum","year":"2005","journal-title":"Curr Opin Microbiol"},{"key":"10.1157\/13091219_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijantimicag.2004.11.006","article-title":"Tigecycline: clinical evidence and formulary positioning","volume":"25","author":"Nathwani","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1157\/13091219_bib64","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Ronald","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13091219_bib65","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/jac\/dkf249","article-title":"In vitro evaluation of BAL9141, a novel parenteral cephalosporin active against oxacillin-resistant staphylococci","volume":"50","author":"Jones","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1157\/13091219_bib66","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"10.1157\/13091219_bib67","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.47.9.3002-3004.2003","article-title":"Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"47","author":"Chiang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1157\/13091219_bib68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1128\/AAC.47.1.418-420.2003","article-title":"In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus","volume":"47","author":"Grohs","year":"2003","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05752228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X05752228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:39:49Z","timestamp":1627605589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X05752228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":68,"alternative-id":["S0213005X05752228"],"URL":"https:\/\/doi.org\/10.1157\/13091219","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}